Mobitz I and Mobitz II describe distinct patterns of second degree heart block that differ in conduction physiology, clinical risk, and management. Understanding how these two types compare is essential for accurate diagnosis and timely intervention in arrhythmia care.
This article explains the key distinctions in a practical, clinically focused format to help you interpret ECG findings and apply them to patient management.
| Type | Mobitz I (Wenckebach) | Mobitz II | Clinical Implication |
|---|---|---|---|
| Location | Atrioventricular (AV) node | His-Purkinje system below AV node | Mobitz II carries higher risk of progression to complete heart block |
| PR Interval Pattern | Progressively lengthens until a beat is dropped | Constant PR interval before sudden dropped beat | Wenckebach shows cyclic lengthening; Mobitz II does not |
| Symptoms | Often asymptomatic or mild lightheadedness | Can cause syncope, fatigue, near-syncope | Presence of symptoms guides urgency of pacing evaluation |
| Prognosis & Management | Often stable; temporary causes may resolve | Higher risk of asystole; pacing often indicated | Mobitz II more frequently requires permanent pacemaker |
Electrophysiology Behind Mobitz I
Mobitz I arises from progressive fatigue within the AV node, where conduction delay increases stepwise with each beat. This decremental conduction produces the characteristic Wenckebach sequence until a P wave fails to conduct, resetting the cycle.
Rate, medications, and enhanced vagal tone can exaggerate this phenomenon, often making Mobitz I a transient and less dangerous conduction disturbance in the setting of otherwise preserved conduction system tissue.
Because the block occurs above the His bundle, escape rhythms usually remain narrow and stable, contributing to a generally better long-term outlook compared to distal conduction disease.
Electrophysiology Behind Mobitz II
Mobitz II results from impaired conduction within the His-Purkinje system, typically distal to the AV node, with a fixed PR interval until a sudden non-conducted P wave appears. This pattern reflects infranodal disease rather than physiological delay.
The conduction block is often abrupt and unpredictable, which can lead to prolonged pauses and compromised cardiac output, raising concern for progression to high-grade or complete heart block.
Because escape rhythms below the block may be wide and slow, the risk of symptomatic bradycardia and sudden pauses is substantially higher, making timely recognition critical.
Clinical Presentation and Risk Stratification
Patients with Mobitz I may report minimal symptoms beyond mild lightheadedness, whereas those with Mobitz II more commonly experience syncope, near-syncope, or exertional intolerance. The difference in symptom burden reflects underlying pathophysiology and ventricular pause risk.
Risk stratification incorporates symptoms, escape rhythm width, and associated findings such as bundle branch block or structural heart disease. Mobitz II with broad QRS complexes or alternating conduction abnormalities is particularly concerning and generally warrants pacemaker evaluation regardless of symptoms.
Clinicians should also evaluate reversible contributors including medications, electrolyte abnormalities, and acute ischemia, as these factors can modify management strategy in both Mobitz I and Mobitz II presentations. Individualized assessment ensures that intervention aligns with overall clinical context rather than conduction pattern alone.
Diagnosis and ECG Criteria
Accurate diagnosis begins with a 12-lead ECG that documents the PR interval pattern, QRS width, and morphology across cycles. In Mobitz I, the progressive PR lengthening followed by a dropped beat is the hallmark, while Mobitz II features unchanging PR intervals until a sudden non-conducted P wave.
Measuring AH and HV intervals during electrophysiologic study can further localize conduction disease, though in many clinical settings ECG findings and clinical context suffice to guide initial management decisions.
Continuous cardiac monitoring and follow-up ECGs help clarify whether the pattern is stable, worsening, or influenced by transient factors, supporting a dynamic rather than static interpretation of second degree block.
Key Takeaways for Clinical Practice
- Recognize the ECG patterns: progressive PR lengthening for Mobitz I, fixed PR with sudden drop for Mobitz II
- Assess symptoms and QRS width to prioritize pacemaker evaluation, especially in Mobitz II
- Review medications and reversible causes before attributing block to intrinsic conduction disease
- Use Holter or telemetry monitoring to capture intermittent block and guide management decisions
- Consider electrophysiology consultation when conduction disease is infranodal or symptoms are recurrent
FAQ
Reader questions
What symptoms typically differentiate Mobitz I from Mobitz II in daily life?
Mobitz I often causes few or no symptoms, whereas Mobitz II more commonly leads to syncope, lightheadedness, or palpitations due to sudden pauses.
Does Mobitz I always require a pacemaker like Mobitz II?
Not usually; Mobitz I often responds to removal of reversible triggers and rarely needs pacing, while Mobitz II frequently requires pacemaker implantation.
How can an ECG tell if the block is at the AV node or in the His-Purkinje system?
Mobitz I with progressive PR lengthening points to AV nodal block, while Mobitz II with fixed PR intervals and sudden drops indicates infranodal, or His-Purkinje, disease.
Can medications cause Mobitz II even if the conduction system is otherwise healthy?
Yes, drugs that slow conduction in the His-Purkinje system, such as certain beta-blockers or calcium channel blockers, can precipitate Mobitz II in susceptible individuals.